From: Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience
Number of dose reductions
N = 18 (%)
1
15 (83)
2
3 (17)
Reason attributed for dose
Fatigue
8 (44)
Diarrhea
Nausea
2 (11)
Neutropenia
Anorexia
Abdominal cramping
1 (6)
Ageusia
Not defined